These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 34389744)
21. Differential expression of Snail1 transcription factor and Snail1-related genes in alveolar and embryonal rhabdomyosarcoma subtypes. Püsküllüoglu M; Lukasiewicz E; Miekus K; Jarocha D; Majka M Folia Histochem Cytobiol; 2010 Dec; 48(4):671-7. PubMed ID: 21478114 [TBL] [Abstract][Full Text] [Related]
22. Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype. Kohashi K; Oda Y; Yamamoto H; Tamiya S; Takahira T; Takahashi Y; Tajiri T; Taguchi T; Suita S; Tsuneyoshi M J Cancer Res Clin Oncol; 2008 Oct; 134(10):1097-103. PubMed ID: 18386058 [TBL] [Abstract][Full Text] [Related]
23. Berberine and palmatine inhibit the growth of human rhabdomyosarcoma cells. Shinji S; Nakamura S; Nihashi Y; Umezawa K; Takaya T Biosci Biotechnol Biochem; 2020 Jan; 84(1):63-75. PubMed ID: 31462179 [TBL] [Abstract][Full Text] [Related]
24. DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation. Megiorni F; Camero S; Ceccarelli S; McDowell HP; Mannarino O; Marampon F; Pizer B; Shukla R; Pizzuti A; Marchese C; Clerico A; Dominici C Oncotarget; 2016 Nov; 7(48):79342-79356. PubMed ID: 27764816 [TBL] [Abstract][Full Text] [Related]
25. MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53. Canner JA; Sobo M; Ball S; Hutzen B; DeAngelis S; Willis W; Studebaker AW; Ding K; Wang S; Yang D; Lin J Br J Cancer; 2009 Sep; 101(5):774-81. PubMed ID: 19707204 [TBL] [Abstract][Full Text] [Related]
26. Close correlation between CXCR4 and VEGF expression and frequent CXCR7 expression in rhabdomyosarcoma. Miyoshi K; Kohashi K; Fushimi F; Yamamoto H; Kishimoto J; Taguchi T; Iwamoto Y; Oda Y Hum Pathol; 2014 Sep; 45(9):1900-9. PubMed ID: 25086956 [TBL] [Abstract][Full Text] [Related]
27. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326 [TBL] [Abstract][Full Text] [Related]
28. Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma. Odeniyide P; Yohe ME; Pollard K; Vaseva AV; Calizo A; Zhang L; Rodriguez FJ; Gross JM; Allen AN; Wan X; Somwar R; Schreck KC; Kessler L; Wang J; Pratilas CA Oncogene; 2022 May; 41(21):2973-2983. PubMed ID: 35459782 [TBL] [Abstract][Full Text] [Related]
31. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice. van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124 [TBL] [Abstract][Full Text] [Related]
32. Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma. Slemmons KK; Crose LE; Rudzinski E; Bentley RC; Linardic CM PLoS One; 2015; 10(10):e0140781. PubMed ID: 26496700 [TBL] [Abstract][Full Text] [Related]
33. Synthetic MIR143-3p Suppresses Cell Growth in Rhabdomyosarcoma Cells by Interrupting RAS Pathways Including PAX3-FOXO1. Sugito N; Heishima K; Ito Y; Akao Y Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182548 [TBL] [Abstract][Full Text] [Related]
34. Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis. Allen-Rhoades W; Lupo PJ; Scheurer ME; Chi YY; Kuttesch JF; Venkatramani R; Meyer WH; Mascarenhas L Cancer Med; 2023 May; 12(9):10222-10229. PubMed ID: 37016270 [TBL] [Abstract][Full Text] [Related]